FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2058598257> ?p ?o ?g. }

• W2058598257 endingPage "85" @default.
• W2058598257 startingPage "78" @default.
• W2058598257 abstract "BackgroundRecent reports have shown that hepatitis E virus (HEV) infection can become chronic in solid-organ transplant recipients, but few studies have systematically investigated the clinical consequences of this chronic HEV infection in solid-organ transplant (SOT) recipients.MethodsWe have undertaken an in-depth study of 6 chronic HEV-infected heart transplant recipients to gain further insight into the clinical, biochemical and virologic presentation of this disorder.ResultsIn 6 patients (2.3%) chronic HEV infection, genotype 3, was identified. Immunosuppression in these patients was tacrolimus-based, combined with either everolimus or prednisolone and/or mycophenolate mofetil. Median follow-up after case detection was 26 months (range 21 to 40 months). All chronic HEV cases had elevated liver enzyme values. IgM antibodies at presentation were positive in 2 of 6 (33%) patients. Liver histology in 4 of 6 (67%) patients showed advanced fibrosis within 2 years after infection. One patient spontaneously cleared the HEV infection: 1 after dose reduction of immunosuppressive therapy and 3 during ribavirin therapy. One patient has yet to clear the virus and remains on ribavirin therapy.ConclusionsChronic HEV infection in heart transplant (HTx) recipients may lead to rapid fibrosis of the liver. We advise additional HEV RNA screening in solid-organ transplant recipients with elevated liver enzymes, because antibody production is often delayed, as demonstrated in these patients. Dose reduction of immunosuppressive therapy should be the first intervention strategy to achieve viral clearance in chronic HEV-infected immunocompromised patients. Ribavirin treatment should be considered in cases of chronic HEV. Recent reports have shown that hepatitis E virus (HEV) infection can become chronic in solid-organ transplant recipients, but few studies have systematically investigated the clinical consequences of this chronic HEV infection in solid-organ transplant (SOT) recipients. We have undertaken an in-depth study of 6 chronic HEV-infected heart transplant recipients to gain further insight into the clinical, biochemical and virologic presentation of this disorder. In 6 patients (2.3%) chronic HEV infection, genotype 3, was identified. Immunosuppression in these patients was tacrolimus-based, combined with either everolimus or prednisolone and/or mycophenolate mofetil. Median follow-up after case detection was 26 months (range 21 to 40 months). All chronic HEV cases had elevated liver enzyme values. IgM antibodies at presentation were positive in 2 of 6 (33%) patients. Liver histology in 4 of 6 (67%) patients showed advanced fibrosis within 2 years after infection. One patient spontaneously cleared the HEV infection: 1 after dose reduction of immunosuppressive therapy and 3 during ribavirin therapy. One patient has yet to clear the virus and remains on ribavirin therapy. Chronic HEV infection in heart transplant (HTx) recipients may lead to rapid fibrosis of the liver. We advise additional HEV RNA screening in solid-organ transplant recipients with elevated liver enzymes, because antibody production is often delayed, as demonstrated in these patients. Dose reduction of immunosuppressive therapy should be the first intervention strategy to achieve viral clearance in chronic HEV-infected immunocompromised patients. Ribavirin treatment should be considered in cases of chronic HEV." @default.
• W2058598257 created "2016-06-24" @default.
• W2058598257 creator A5005200745 @default.
• W2058598257 creator A5012442242 @default.
• W2058598257 creator A5018450847 @default.
• W2058598257 creator A5022452075 @default.
• W2058598257 creator A5024615976 @default.
• W2058598257 creator A5034747765 @default.
• W2058598257 creator A5055897030 @default.
• W2058598257 creator A5067828032 @default.
• W2058598257 date "2013-01-01" @default.
• W2058598257 modified "2023-09-25" @default.
• W2058598257 title "Clinical implications of chronic hepatitis E virus infection in heart transplant recipients" @default.
• W2058598257 cites W1671822578 @default.
• W2058598257 cites W1928114211 @default.
• W2058598257 cites W1969251068 @default.
• W2058598257 cites W1978355300 @default.
• W2058598257 cites W1978736312 @default.
• W2058598257 cites W2007808640 @default.
• W2058598257 cites W2012382212 @default.
• W2058598257 cites W2020696267 @default.
• W2058598257 cites W2029421029 @default.
• W2058598257 cites W2033605315 @default.
• W2058598257 cites W2035491916 @default.
• W2058598257 cites W2048321197 @default.
• W2058598257 cites W2060676541 @default.
• W2058598257 cites W2071410271 @default.
• W2058598257 cites W2077382130 @default.
• W2058598257 cites W2087829753 @default.
• W2058598257 cites W2096952795 @default.
• W2058598257 cites W2100255019 @default.
• W2058598257 cites W2115956200 @default.
• W2058598257 cites W2123700681 @default.
• W2058598257 cites W2139276943 @default.
• W2058598257 cites W2145745072 @default.
• W2058598257 cites W2156915517 @default.
• W2058598257 cites W2168479171 @default.
• W2058598257 doi "https://doi.org/10.1016/j.healun.2012.10.008" @default.
• W2058598257 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23260707" @default.
• W2058598257 hasPublicationYear "2013" @default.
• W2058598257 type Work @default.
• W2058598257 sameAs 2058598257 @default.
• W2058598257 citedByCount "59" @default.
• W2058598257 countsByYear W20585982572013 @default.
• W2058598257 countsByYear W20585982572014 @default.
• W2058598257 countsByYear W20585982572015 @default.
• W2058598257 countsByYear W20585982572016 @default.
• W2058598257 countsByYear W20585982572017 @default.
• W2058598257 countsByYear W20585982572018 @default.
• W2058598257 countsByYear W20585982572019 @default.
• W2058598257 countsByYear W20585982572020 @default.
• W2058598257 countsByYear W20585982572021 @default.
• W2058598257 countsByYear W20585982572022 @default.
• W2058598257 countsByYear W20585982572023 @default.
• W2058598257 crossrefType "journal-article" @default.
• W2058598257 hasAuthorship W2058598257A5005200745 @default.
• W2058598257 hasAuthorship W2058598257A5012442242 @default.
• W2058598257 hasAuthorship W2058598257A5018450847 @default.
• W2058598257 hasAuthorship W2058598257A5022452075 @default.
• W2058598257 hasAuthorship W2058598257A5024615976 @default.
• W2058598257 hasAuthorship W2058598257A5034747765 @default.
• W2058598257 hasAuthorship W2058598257A5055897030 @default.
• W2058598257 hasAuthorship W2058598257A5067828032 @default.
• W2058598257 hasConcept C104317684 @default.
• W2058598257 hasConcept C126322002 @default.
• W2058598257 hasConcept C135763542 @default.
• W2058598257 hasConcept C168444539 @default.
• W2058598257 hasConcept C185592680 @default.
• W2058598257 hasConcept C203014093 @default.
• W2058598257 hasConcept C2522874641 @default.
• W2058598257 hasConcept C2776408679 @default.
• W2058598257 hasConcept C2780040827 @default.
• W2058598257 hasConcept C2780252810 @default.
• W2058598257 hasConcept C2780777367 @default.
• W2058598257 hasConcept C2909675724 @default.
• W2058598257 hasConcept C2911091166 @default.
• W2058598257 hasConcept C3019392825 @default.
• W2058598257 hasConcept C55493867 @default.
• W2058598257 hasConcept C71924100 @default.
• W2058598257 hasConcept C8891405 @default.
• W2058598257 hasConcept C90924648 @default.
• W2058598257 hasConceptScore W2058598257C104317684 @default.
• W2058598257 hasConceptScore W2058598257C126322002 @default.
• W2058598257 hasConceptScore W2058598257C135763542 @default.
• W2058598257 hasConceptScore W2058598257C168444539 @default.
• W2058598257 hasConceptScore W2058598257C185592680 @default.
• W2058598257 hasConceptScore W2058598257C203014093 @default.
• W2058598257 hasConceptScore W2058598257C2522874641 @default.
• W2058598257 hasConceptScore W2058598257C2776408679 @default.
• W2058598257 hasConceptScore W2058598257C2780040827 @default.
• W2058598257 hasConceptScore W2058598257C2780252810 @default.
• W2058598257 hasConceptScore W2058598257C2780777367 @default.
• W2058598257 hasConceptScore W2058598257C2909675724 @default.
• W2058598257 hasConceptScore W2058598257C2911091166 @default.
• W2058598257 hasConceptScore W2058598257C3019392825 @default.
• W2058598257 hasConceptScore W2058598257C55493867 @default.
• W2058598257 hasConceptScore W2058598257C71924100 @default.
• W2058598257 hasConceptScore W2058598257C8891405 @default.

• next